Scarica l'app Stockscreener
0.9627
2.81%
-0.0278
Dopo l'orario di chiusura:
.98
0.0173
+1.80%
Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie
Nautilus Biotechnology, Inc. SEC Filing (Sep 21, 2026) - stocktitan.net
Nautilus Biotechnology details Iterative Mapping for tau proteoform profiling in new video - Traders Union
Nautilus Biotechnology Establishes New At-The-Market Offering - The Globe and Mail
Andreessen Horowitz stake in Nautilus (NASDAQ: NAUT) falls below 5% - stocktitan.net
Nautilus Biotechnology May Offer Up To $300 Million Of SecuritiesSEC Filing - TradingView
Nautilus Biotechnology Launches $125 Million ATM Program With TD Cowen; Agent Fee Up to 3% - TradingView
Nautilus Biotechnology (NASDAQ: NAUT) lines up new $300M fundraising capacity - Stock Titan
Nautilus Biotechnology Files $300 Million Shelf Registration - Yahoo Finance
Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms - Investing News Network
Nautilus Biotechnology paper on tau proteoform analysis published in Nature Methods - Traders Union
Nautilus found 130 forms of a protein linked to Alzheimer’s. Some appeared in just 0.1% of samples. - Stock Titan
Nautilus Biotechnology (NAUT) Advances 3.81% to $0.96, Testing Move Toward Key $1.01 ResistanceWyckoff Accumulation - dars.gov.et
Nautilus Biotechnology heads to HUPO 2026 to unveil Voyager platform breakthroughs - Traders Union
Andreessen Horowitz sells Nautilus (NAUT) shares around $1 - Stock Titan
Nautilus (NAUT) Q2 2026 Results: EPS Exceeds Its Estimate for the Current Session; Trading Move: The Stock Records a 0.69% Increase at the ClosePre-Announcement Alert - dars.gov.et
Nautilus (NAUT) Market: Finishes 8.30% Down at $0.88 in the Latest Session; Price Levels: the Session Ends Within the Reported Technical BoundariesValue Area Low - vinanet.vn
Nautilus (NAUT) Financial Results: Profit Per Share Surpasses Its Benchmark in the Current Update; Trading Move - vinanet.vn
Nautilus Biotechnology urges new methods to address biological validation challenge in proteomics - Traders Union
Nautilus (NAUT) Watch: Closes 5.82% Higher at $0.90; Technical View: Traders Can Monitor the $0.85-$0.95 Range for the Current SessionSystematic Flow - vinanet.vn
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Sees Significant Increase in Short Interest - MarketBeat
Nautilus Biotechnology Earnings Call Balances Promise and Risk - TipRanks
NAUT Q2 2026 Earnings: Narrower Loss Surprise Lifts Shares 22%Earnings Deceleration Risk - vinanet.vn
Perceptive Advisors group reports 9.1% Nautilus (NAUT) ownership in updated 13D/A - Stock Titan
Nautilus Biotechnology (NAUT) Slides 3.9% to $0.86, Approaching Key Support LevelLiquidity Order Flow - vinanet.vn
Nautilus Biotechnology (NAUT) Steadies Near $0.89 as Support HoldsMonthly Profile - careplusvn.com
Nautilus Biotechnology Inc (NASDAQ: NAUT) Share Price, NAUT Stock News, NAUT Share Price & Updates - Kalkine
Nautilus Biotechnology (NAUT) Institutional Ownership 2026 - MarketBeat
Nautilus Biotechnology unveils new proteomics approach for dementia studies - Traders Union
Nautilus Biotechnology: A Contrarian Proteoformics Play After Recent Pullback (NAUT) - Seeking Alpha
Nautilus Biotechnology, Inc. Revenue Breakdown – NASDAQ:NAUT - TradingView
Short Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Rises By 74.6% - MarketBeat
Nautilus Biotechnology sets 31 July deadline for Iterative Mapping Grant Program applications - tradersunion.com
Nautilus Biotechnology Inc (NAUT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nautilus Biotechnology, Inc. 2026: Revenue $190K, EPS ($0.11) — 10-Q Summary - tradingview.com
Nautilus Biotechnology Q2 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Nautilus Biotechnology beats Q2 2026 EPS forecast - Investing.com
Nautilus Biotechnology Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Nautilus Biotechnology posts first revenue, Q2 net loss narrows - TradingView
Nautilus Biotechnology (NASDAQ: NAUT) shifts roadmap after Q2 2026 results - Stock Titan
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results - Yahoo Finance
Nautilus Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
NAUT|Nautilus Biotechnology Inc|Price:0.977|Chg%:-0.053 - TradingKey
Nautilus Biotechnology reports Q2 2026: $0.2M revenue, $14.5M net loss, $129.2M cash - TradingView
Nautilus Biotechnology Reports $190,000 Revenue in Second Quarter 2026 - Quiver Quantitative
Price to earnings forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Nautilus Biotechnology Inc (NAUT) Cash Flow - TradingKey
Nautilus Biotechnology Inc (NAUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NAUT|Nautilus Biotechnology Inc|Price:1.690|Chg%:-0.080 - TradingKey
Nautilus Biotechnology Inc (NAUT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NAUT|Nautilus Biotechnology Inc|Price:0.980|Chg%:-0.005 - TradingKey
Nautilus Biotechnology Inc (NAUT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nautilus Biotechnology Inc (NAUT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NAUT|Nautilus Biotechnology Inc|Price:1.670|Chg%:-0.020 - TradingKey
Nautilus Biotechnology Inc (NAUT) Risk Assessment: Volatility, Financial Risk & Investment Risk - tradingkey.com
Nautilus Biotechnology Inc (NAUT) Institutional Confidence - TradingKey
TradingKey - TradingKey
Nautilus Biotechnology Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
NAUT Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Nautilus Biotechnology invites project proposals for Tau Proteoforms Assay grant program - Traders Union
Nautilus Biotechnology (NAUT) Surges 6.1%: Breakout Above Key Support Zone Triggers Buying MomentumCTA Positioning - dars.gov.et
Nautilus Biotechnology2026 Funding Rounds & List of Investors - Tracxn
Nautilus Biotechnology (NAUT) Stages a Recovery: Can the Breakout Hold?Trend Reversal Picks - careplusvn.com
Nautilus Biotechnology (NAUT) Posts Modest Decline as Shares Hover Near Support ZoneTrade Entry Signals - vinanet.vn
Nautilus Biotechnology And 2 Promising Penny Stocks To Consider - Sahm
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):